growth stocks

Vihari Ross from Antipodes and James Tsinidis from Munro Partners analyse five global stocks with multi-decade growth opportunities ahead.

Despite sky-high valuations, Jun Bei Liu is bullish on Pro Medicus. She first bought at $25 - now it’s 10x’d. How much higher can it climb?

A year ago, we asked whether AI will ever be able to pick stocks like a human. As the headline suggests, the current answer is 'not yet'.

First Sentier's David Wilson and Elston's Joe McCarthy pick apart companies with strong sales growth - is it all it's cracked up to be?

'Cloning' top fund managers can be a winning strategy. Check out 3 ASX growth stocks that are worth a further look.

Elston's Joe McCarthy and First Sentier's David Wilson share their tips for hunting great growth stocks, and an example for good measure

Could this Australian-American healthcare stalwart hit $60/share?

Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025

Rudi Filapek-Vandyck, Michael Wayne, and Henry Jennings each boldly nominate the one ASX stock they believe will hit $500 first.

In this wire, we crunch the data on the country's top-performing Aussie equities funds and examine their 2025 positioning.